Klotho Neurosciences Inc/$KLTO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Klotho Neurosciences Inc
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.
Ticker
$KLTO
Sector
Primary listing
Employees
3
Headquarters
Website
KLTO Metrics
BasicAdvanced
$34M
-
-$0.42
2.54
-
Price and volume
Market cap
$34M
Beta
2.54
52-week high
$3.91
52-week low
$0.11
Average daily volume
2.1M
Financial strength
Current ratio
135.738
Quick ratio
133.905
Interest coverage (TTM)
-3.09%
Profitability
Management effectiveness
Return on assets (TTM)
-72.43%
Return on equity (TTM)
-249.56%
Valuation
Price to book
2.72
Price to tangible book (TTM)
3.47
Price to free cash flow (TTM)
-2.66
Free cash flow yield (TTM)
-37.60%
Free cash flow per share (TTM)
-0.207
Growth
Earnings per share change (TTM)
352.76%
KLTO News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Klotho Neurosciences Inc stock?
Klotho Neurosciences Inc (KLTO) has a market cap of $34M as of September 19, 2025.
What is the P/E ratio for Klotho Neurosciences Inc stock?
The price to earnings (P/E) ratio for Klotho Neurosciences Inc (KLTO) stock is 0 as of September 19, 2025.
Does Klotho Neurosciences Inc stock pay dividends?
No, Klotho Neurosciences Inc (KLTO) stock does not pay dividends to its shareholders as of September 19, 2025.
When is the next Klotho Neurosciences Inc dividend payment date?
Klotho Neurosciences Inc (KLTO) stock does not pay dividends to its shareholders.
What is the beta indicator for Klotho Neurosciences Inc?
Klotho Neurosciences Inc (KLTO) has a beta rating of 2.54. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.